Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018

Size: px
Start display at page:

Download "Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018"

Transcription

1 Wund Care Equipment and Supply Benefits t Change fr Texas Medicaid July 1, 2018 Infrmatin psted May 11, 2018 Nte: Texas Medicaid managed care rganizatins (MCOs) must prvide all medically necessary, Medicaid-cvered services t eligible clients. Administrative prcedures such as prir authrizatin, pre-certificatin, referrals, and claims/encunter data filing may differ frm traditinal Medicaid (fee-fr-service) and frm MCO t MCO. Prviders shuld cntact the client's specific MCO fr details. Effective fr dates f service n r after July 1, 2018, wund care equipment and supply benefits will change fr Texas Medicaid. Overview f Benefit Changes Majr changes t this medical benefit plicy include the fllwing: Updated benefit language Revised quantity limitatins New prir authrizatin criteria Updated dcumentatin requirements New prir authrizatin frm Place f service and prvider type updates Updated Benefit Language Wunds are defined as acute r chrnic, as fllws: Acute wunds prgress thrugh the nrmal stages f wund healing and shw definite signs f healing within fur weeks. Chrnic wunds d nt prgress nrmally thrugh the stages f healing (ften getting stalled in ne phase) and d nt shw evidence f healing within fur weeks. Prviders are t cnsider the clinical efficacy f the wund care prduct, the client s functinal status, as well as the measurable signs f effective wund management when rdering prducts t treat wunds. Measureable signs f wund management include, but are nt limited t, the fllwing: A decrease in wund size, either in surface area r vlume A decrease in amunt f exudate A decrease in amunt f necrtic tissue Imprved infectin status Cleansers Wund cleansing helps create an ptimal healing envirnment and decreases the ptential fr infectin. Cleansing agents and methds vary based n effectiveness and

2 individual client needs. Wund cleansing agents may include, but are nt limited t, the fllwing: Nrmal saline Cmmercial wund cleansers Pvidne idine Hydrgen perxide Sdium hypchlrite Cmpressin Cmpressin dressings, wraps r stckings apply pressure t bdy parts t cntrl edema and aid circulatin by redirecting bld centrally. Belw the knee and abve the knee cmpressin stckings may be benefits fr Texas Medicaid clients. Cmpressin dressings r stckings may be used fr, but nt limited t, the fllwing indicatins: Edema in pregnancy Pstural hyptensin Lymphedema Treatment f any f the fllwing cmplicatins f chrnic venus insufficiency: Venus edema Stasis ulcers Varicse veins (nt including spider veins) Lipdermatsclersis Custm burn cmpressin garments may be a benefit with prir authrizatin and dcumentatin supprting medical necessity. Dressings A dressing is a wet r dry, sterile r nn-sterile, pad r cmpress that is designed t be in direct cntact with the wund. A dressing is applied t prmte healing and prtect the wund frm further harm. Dressings and related supplies may include, but are nt limited t, the fllwing: Wund packing and fillers Gauze, impregnated r nn-impregnated, sterile r nn-sterile Dry dressings Cllagen dressings Alginate r ther fiber gelling dressings Cmpsite dressings Antimicrbials Fam dressings

3 Cntact layers and transparent films Hydrcllid, Hydrfiber, and Hydrgel dressings Specialty absrptive dressings Cmpressin dressings and wraps Tape t secure dressings Additinal Exclusins The fllwing services are nt a benefit f Texas Medicaid: Cntact r nn-cntact ultrasund treatment fr wunds Electrchemical lw-dse tissue xygenatin systems Quantity Limitatins The fllwing quantity limitatins will be effective fr dates f service n r after July 1, 2018: Table A: Prcedure Cdes Limitatin Effective July 1, 2018 A4213 A4216 A4217 A4244 A4246 A4247 A4320 A4322 A4364 A4450 A4452 A4455 A4456 A4461 A4465 A4490 A4495 A4500 A4510 A4927 A per mnth 10 per mnth 4 per mnth 4 per mnth 6 per mnth 15 per mnth 8 per mnth 100 per mnth 100 per mnth 4 per mnth 60 per mnth 4 per mnth 4 per year 4 per year 4 per year 4 per year 1 per mnth 50 per mnth

4 A5121 A5122 A5126 A6010 A6011 A6021 A6022 A6023 A6024 A6025 A6196 A6197 A6198 A6199 A6203 A6204 A6205 A6206 A6207 A6208 A6209 A6210 A6211 A6212 A6213 A6214 A6216 A6217 A6218 A6219 A6220 A6221 A6222 A6223 A6224 A6228 A per mnth 40 per mnth 10 per mnth 10 per mnth 10 per mnth 2 per mnth 4 per mnth 15 per mnth 15 per mnth 4 per mnth 15 per mnth 10 per mnth 60 per mnth 4 per mnth 15 per mnth 4 per mnth 10 per mnth 200 per mnth 200 per mnth 15 per mnth 120 per mnth 15 per mnth 60 per mnth 60 per mnth 60 per mnth 120 per mnth

5 A6230 A6231 A6232 A6233 A6234 A6235 A6236 A6237 A6238 A6239 A6240 A6241 A6242 A6243 A6244 A6245 A6246 A6247 A6248 A6250 A6251 A6252 A6253 A6254 A6255 A6256 A6257 A6258 A6259 A6261 A6262 A6266 A6402 A6403 A6404 A6407 A per mnth 60 per mnth 10 per mnth 15 per mnth 10 per mnth 10 per mnth 15 per mnth 8 per mnth 15 per mnth 15 per mnth 4 per mnth 10 per mnth 8 per mnth 2 per mnth 60 per mnth 15 per mnth 60 per mnth 15 per mnth 15 per mnth 8 per mnth 8 per mnth 120 per mnth 200 per mnth 100 per mnth 15 per mnth 60 per mnth

6 A6411 A6412 A6441 A6442 A6443 A6444 A6445 A6446 A6447 A6448 A6449 A6450 A6451 A6452 A6453 A6454 A6455 A6456 A6457 A6530 A6531 A6532 A6533 A6534 A6535 A6536 A6537 A6538 A6539 A6540 A6541 A6544 A6545 with mdifier AW A6550 A per mnth 120 per mnth 120 per mnth 120 per mnth 120 per mnth 120 per mnth 120 per mnth 60 per mnth 60 per mnth 60 per mnth 60 per mnth 60 per mnth 4 per year 8 per year 15 per mnth 10 per mnth E2402* 1 per mnth fr up t 3 mnths *Nte: The initial 90 days f treatment with negative pressure wund therapy des nt require prir authrizatin. Prir authrizatin is required fr cntinued

7 therapy after the initial 90 days f treatment. New Prir Authrizatin Criteria Quantities that exceed the limitatins identified in the tables abve will require prir authrizatin with dcumentatin supprting medical necessity. Prir authrizatin with dcumentatin supprting medical necessity and the quantity requested, will be required fr the fllwing prcedure cdes: Table B: Prcedure Cdes A6215 A6260 A6501 A6502 A6503 A6504 A6505 A6506 A6507 A6508 A6509 A6510 A6511 A6512 A6513 A6549 A9272 T1999 Infrmatin frm the sectin belw, Updated Dcumentatin Requirements, must be submitted anytime that prir authrizatin is required. Cmpressin Burn Garments The fllwing prcedure cdes fr cmpressin burn garments will require dcumentatin f an apprpriate diagnsis and evidence f medical necessity: Table C: Prcedure Cdes A6501 A6502 A6503 A6504 A6505 A6506 A6507 A6508 A6509 A6510 A6511 A6512 A6513 Prir authrizatin requests fr cmpressin burn garments will be reviewed by the medical directr. Dispsable Wund Suctin Dcumentatin fr prcedure cde A9272 must include justificatin addressing why n ther wund care equipment and supplies will meet the client s need. Negative Pressure Wund Therapy (NPWT) Prir authrizatin fr NPWT may be cnsidered fr additinal 30-day treatment perids beynd the initial 90-day treatment perid. Fr each prir authrizatin request, prviders must submit dcumentatin t supprt cntinued use f NPWT, including the measurements at the initiatin f NPWT and the current measurements (length, width, depth and any undermining r tunneling.) Prviders must als dcument if any f the fllwing cntraindicatins are present: N measurable imprvement f wund status ccurring ver the prir 90-day perid The wund care equipment r supplies are n lnger being used by the client as prescribed

8 Updated Dcumentatin Requirements The requesting durable medical equipment (DME) prvider may be asked fr additinal infrmatin t clarify r cmplete a request fr the wund care equipment r supplies including, but nt limited t, the fllwing: Overall health status f clients whse wunds are nt prgressing thrugh the nrmal stages f healing, including, but nt limited t, the fllwing: Albumin r pre-albumin (within 30 days) Hemglbin A1C (within 30 days) Use f pressure-reducing surfaces, repsitining, and encuraged ambulatin Reauthrizatin will be cnsidered based n medical necessity, with a new prir authrizatin request. All f the fllwing infrmatin must be submitted with every prir authrizatin request. If prir authrizatin is nt required, this dcumentatin must be maintained in the client s medical recrd and is subject t retrspective review. Categry 1: Medical Histry and Cmpliance A cmprehensive treatment plan, including the prescribed wund care and management planned fr the client. This may include, but is nt limited t, dcumentatin f the fllwing: Any medical diagnsis r chrnic cnditin that affects wund healing Histry f previus wund care treatments and utcmes with dates (including therapies initiated in a hspital r skilled nursing facility) Cntinued management f unreslved cmpliance issues (e.g., missed medical appintments, refusing dressing changes, repsitining, smking, pr nutritinal intake r chices) Whether a family member, friend r caregiver agrees t be available t assist the client Categry 2: Wund Care Interventins Relevant infrmatin related t the current wund, including the fllwing: Any mechanical, surgical, enzymatic r autlytic tissue debridement (if perfrmed) Treatment fr infectin (if present) Categry 3: Wund Descriptin & Details Detailed descriptin f the wund, including the fllwing: Dates f previus and current assessments The measurements at the initiatin f wund care and the current measurements, including length, width, depth and any undermining r tunneling Wund clr

9 Amunt, quality, quantity and dr f drainage (if present) Presence f granulatin r eschar (if apprpriate) The currently prescribed wund care regimen, t include types f dressings, frequency f dressing changes and supplies needed fr each dressing change Frequency client will be seen by a licensed medical prfessinal t assess wund healing and current wund treatment regimen Categry 4: Cntraindicatins Absence f the fllwing cntraindicatins: Untreated stemyelitis within the vicinity f the wund Wund ischemia Gangrene Presence in the wund f necrtic tissue with eschar (if debridement has nt been attempted) Cancer present in the wund r arund the margins Presence f a fistula t an rgan r bdy cavity within the vicinity f the wund Dcumentatin explaining the apprpriateness f wund care is required if any f the abve cntraindicatins are present New Prir Authrizatin Frm The new prir authrizatin frm, titled Wund Care Equipment and Supplies Order Frm, is t be used when submitting prir authrizatin requests fr the fllwing services: Wund care supplies that exceed quantity limitatins All wund care supplies that require prir authrizatin, as identified in Table B abve The fllwing frms will be discntinued n June 30, 2018, and will n lnger be accepted after July 31, 2018: Statement fr Initial Wund Therapy System In-Hme Use (Frm #F00100) Statement fr Recertificatin f Wund Therapy System In-Hme Use (Frm #F00099) Prviders may refer t the article titled, "New Prir Authrizatin Frm fr Wund Care Equipment and Supplies t be Effective July 1, 2018," which was published n this website May 11, 2018, fr additinal infrmatin abut the new frm. Place f Service and Prvider Type Updates The fllwing prcedure cdes will nly be a benefit when services are prvided by hme health DME and medical supplier (DME) prviders in the hme setting: Table D:

10 Prcedure Cdes A4490 A4495 A4500 A4510 A6544 The fllwing prcedure cdes will nly be a benefit when services are prvided by hme health DME and medical supplier (DME) prviders in the hme setting, and hspital prviders in the utpatient hspital setting: Table E: Prcedure Cdes A6501 A6502 A6503 A6504 A6505 A6506 A6507 A6508 A6509 A6510 A6511 A6512 A6513 Fr mre infrmatin, call the TMHP Cntact Center at r the TMHP- CSHCN Services Prgram Cntact Center at

o Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis

o Venous edema o Stasis ulcers o Varicose veins (not including spider veins) o Lipodermatosclerosis Wound Care Equipment and Supply Benefits to Change for Texas Medicaid July 1, 2018 Effective for dates of service on or after July 1, 2018, wound care equipment and supply benefits will change for Texas

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009

CSHCN Services Program Benefits to Change for Outpatient Behavioral Health Services Information posted November 10, 2009 CSHCN Services Prgram Benefits t Change fr Outpatient Behaviral Health Services Infrmatin psted Nvember 10, 2009 Effective fr dates f service n r after January 1, 2010, benefit criteria fr utpatient behaviral

More information

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria

Benefits for Anesthesia Services for the CSHCN Services Program to Change Effective for dates of service on or after July 1, 2008, benefit criteria Benefits fr Anesthesia Services fr the CSHCN Services Prgram t Change Effective fr dates f service n r after July 1, 2008, benefit criteria fr anesthesia will change fr the Children with Special Health

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

Cardiac Rehabilitation Services

Cardiac Rehabilitation Services Dcumentatin Guidance N. DG1011 Cardiac Rehabilitatin Services Revisin Letter A 1.0 Purpse The Centers fr Medicare and Medicaid Services (CMS) has detailed specific dcumentatin requirements fr Cardiac Rehabilitatin

More information

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan

Bariatric Surgery FAQs for Employees in the GRMC Group Health Plan Bariatric Surgery FAQs fr Emplyees in the GRMC Grup Health Plan Gergia Regents Medical Center and Gergia Regents Medical Assciates emplyees and eligible dependents wh are in the GRMC Grup Health Plan (Select

More information

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES.

UNM SRMC SLEEP MEDICINE CLINICAL PRIVILEGES. Initial privileges (initial appintment) Renewal f privileges (reappintment) Expansin f privileges (mdificatin) INSTRUCTIONS All new applicants must meet the fllwing requirements as apprved by the UNM SRMC

More information

Related Policies None

Related Policies None Medical Plicy MP 3.01.501 Guidelines fr Cverage f Mental and Behaviral Health Services Last Review: 8/30/2017 Effective Date: 8/30/2017 Sectin: Mental Health End Date: 08/19/2018 Related Plicies Nne DISCLAIMER

More information

Benefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016

Benefits to Change for Diagnostic and Surgical/Reconstructive Breast Therapies and Corrective Procedures January 1, 2016 Benefits t Change fr Diagnstic and Surgical/Recnstructive Breast Therapies and Crrective Prcedures January 1, 2016 Infrmatin psted Nvember 13, 2015 Effective fr dates f service n r after January 1, 2016,

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Plicy Name: Plicy Number: Respnsible Department(s): CLINICAL MEDICAL POLICY Supervised Exercise Therapy fr Peripheral Artery Disease (PAD) MP-077-MD-DE Medical Management Prvider Ntice Date: 01/15/2019

More information

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO NIA Magellan 1 Spine Care Prgram Interventinal Pain Management Frequently Asked Questins (FAQs) Fr Medicare Advantage HMO and PPO Questin GENERAL Why is Flrida Blue implementing a Spine Management prgram

More information

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year Health Screening Recrd: Entry Level MIDWIFERY EDUCATION PROGRAM HEALTH SCREENING REQUIREMENTS (Rev. June 2017) 1. Hepatitis B: Primary vaccinatin series (3 vaccines 0, 1 and 6 mnths apart), plus serlgic

More information

Indications and Limitations of Coverage and/or Medical back to top

Indications and Limitations of Coverage and/or Medical back to top Fr services perfrmed n r after 09/15/2009 Original Determinatin Ending Date Revisin Effective Date Revisin Ending Date Indicatins and Limitatins f Cverage and/r Medical Necessity Indicatins Medicare cverage

More information

Physical, Occupational, and Speech Therapy - Children (Acute and Chronic)

Physical, Occupational, and Speech Therapy - Children (Acute and Chronic) Physical, Occupatinal, and Speech Therapy - Children (Acute and Chrnic) Infrmatin psted May 6, 2016 Nte: This article applies t claims submitted t TMHP fr prcessing. Fr claims prcessed by a Medicaid managed

More information

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit.

PROVIDER ALERT. Comprehensive Diagnostic Evaluation (CDE) Guidelines to Access the Applied Behavior Analysis (ABA) Benefit. Cmprehensive Diagnstic Evaluatin (CDE) Guidelines t Access the Applied Behavir Analysis (ABA) Benefit May 5, 2017 Clinical infrmatin that utlines medical necessity is required t supprt the need fr initial

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQ s) Fr PA Health & Wellness Prviders Questin GENERAL Why is PA Health & Wellness implementing a Medical Specialty Slutins Prgram? Answer

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS) Questin GENERAL Why did MHS implement a Medical Specialty Slutins Prgram? Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Managed Health Services (MHS) Answer Effective Nvember

More information

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training Iwa Early Peridic Screening, Diagnsis and Treatment Care fr Kids Prgram Prvider Training The Early Peridic Screening, Diagnsis and Treatment (EPSDT) Care fr Kids prgram is Iwa s Medicaid prgram fr children.

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Lower Extremity Amputation (LEA) Considerations / Issues

Lower Extremity Amputation (LEA) Considerations / Issues Lwer Extremity Amputatin (LEA) Cnsideratins / Issues Prviding Te Fillers can be an advantageus resurce fr yur patient and business but it als cmes with certain cnsideratins. Please review this list belw

More information

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers Natinal Imaging Assciates, Inc. (NIA) Frequently Asked Questins (FAQs) Fr Luisiana Healthcare Cnnectins Prviders Questin GENERAL Why did Luisiana Healthcare Cnnectins implement a Medical Prgram? Answer

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information

Referral Criteria: Inflammation of the Spine Feb

Referral Criteria: Inflammation of the Spine Feb Referral Criteria: Inflammatin f the Spine Feb 2019 1 5.7. Inflammatin f the Spine Backgrund Ankylsing spndylitis and axial spndylarthrpathy are fund in arund 0.3-1.2% f the ppulatin. Spndylarthritis encmpasses

More information

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST

LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST OPTUM LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY / APPLIED BEHAVIOR ANALYSIS FOR AUTISM SPECTRUM DISORDER HAWAII MEDICAID QUEST LEVEL OF CARE GUIDELINES: INTENSIVE BEHAVIORAL THERAPY/APPLIED

More information

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57

Reference: Patient A. Brenda WXXXXX Date of Birth: 4/15/57 Reference: Patient A Brenda WXXXXX Date f Birth: 4/15/57 49 year ld white female patient presented n July 20, 2006 with chief cmplaint f stage 4 cancer, initially diagnsed in Octber, 2003 with Cervical

More information

Rate Lock Policy. Contents

Rate Lock Policy. Contents Rate Lck Plicy Cntents Rate Lcks... 2 Rate Lck Cnfirmatin... 2 Lck Term... 2 Pre-Lck... 2 Maximum Qualified Rate... 3 Extensins... 3 Cst t Extend... 3 Relcks... 4 Re-Negtiatin r Flat Dwn Plicy... 4 Prgram

More information

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018) Breast Cancer Awareness Mnth 2018 Key Messages (as f June 6, 2018) In this dcument there are tw sectins f messages in supprt f Cancer Care Ontari s Breast Cancer Awareness Mnth 2018: 1. Campaign key messages

More information

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator

Continuous Quality Improvement: Treatment Record Reviews. Third Thursday Provider Call (August 20, 2015) Wendy Bowlin, QM Administrator Cntinuus Quality Imprvement: Treatment Recrd Reviews Third Thursday Prvider Call (August 20, 2015) Wendy Bwlin, QM Administratr Gals f the Presentatin Review the findings f Treatment Recrd Review results

More information

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient

o Procedures performed o Diagnoses Identified o Certain devices/equipment/supplies acquired for patient Image Surce: https://s-media-cache-ak0.pinimg.cm/736x/7c/29/91/7c2991805f004e1ca05e42a79883f4a7.jpg 6/30/2017 Curse Objectives A Practical Guide t Cding fr Audilgists in 2017 Megan Keirans, AuD University

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Orencia (abatacept) Applicable Medical Benefit x Effective: 2/21/18 Pharmacy- Frmulary 1 x Next Review: 12/18 Pharmacy- Frmulary 2 x Date f Origin: 11/28/06 Pharmacy- Frmulary 3/Exclusive

More information

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will:

Nutrition Care Process Model Tutorials. Nutrition Monitoring & Evaluation: Overview & Definition. By the end of this module, the participant will: Nutritin Care Prcess Mdel Tutrials Nutritin Care Prcess and Terminlgy Cmmittee Academy f Nutritin and Dietetics Nutritin Care Prcess Terminlgy 2015 Editin Nutritin Mnitring & Evaluatin: Overview & Definitin

More information

Folotyn (pralatrexate)

Folotyn (pralatrexate) Fltyn (pralatrexate) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Original Effective Date: 10/01/2015 Current Effective Date: 01/01/2018TBD03/01/2017 POLICY A. INDICATIONS The indicatins

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.

More information

LTCH QUALITY REPORTING PROGRAM

LTCH QUALITY REPORTING PROGRAM 4 LTCH QUALITY REPORTING PROGRAM GENERAL INFORMATION...3 LTCH FACILITY-LEVEL QUALITY MEASURE REPORT...5 LTCH PATIENT-LEVEL QUALITY MEASURE REPORT...18 LTCH REVIEW AND CORRECT REPORT...23 09/2018 v1.04

More information

APPENDIX A Certification of Advanced Disease:

APPENDIX A Certification of Advanced Disease: APPENDIX A Certificatin f Advanced Disease: Name: DOB: Member ID: Name f Palliative Care Prgram: A. General Criteria: Check each f the fllwing that apply (All needed fr eligibility). Patient wh is likely

More information

HEDIS. Healthcare Effectiveness Data & Information Set (HEDIS ) QUALITY MANAGEMENT PROGRAM SECTION 8

HEDIS. Healthcare Effectiveness Data & Information Set (HEDIS ) QUALITY MANAGEMENT PROGRAM SECTION 8 HEDIS Healthcare Effectiveness Data & Infrmatin Set (HEDIS ) The HEDIS â audit cntains a cre set f perfrmance measures that prvide infrmatin abut custmer satisfactin, specific health care measures, and

More information

Oxfordshire CCG Service Specification Management of Venous and Mixed Aetiology Leg Ulcers Requiring Compression Therapy

Oxfordshire CCG Service Specification Management of Venous and Mixed Aetiology Leg Ulcers Requiring Compression Therapy Oxfrdshire CCG Service Specificatin 2017-18 Management f Venus and Mixed Aetilgy Leg Ulcers Requiring Cmpressin Therapy 1. Backgrund Current best practice and natinal guidelines recmmend the use f high

More information

Immunisation and Disease Prevention Policy

Immunisation and Disease Prevention Policy Immunisatin and Disease Preventin Plicy Quality Area 2: Children s Health and Safety 2.1 Each child s health is prmted 2.1.4 Steps are taken t cntrl the spread f infectius diseases and t manage injuries

More information

Limitations and Exclusions (What is Not Covered)

Limitations and Exclusions (What is Not Covered) Clrad Dental Family + Pediatric Plan Exclusins and Limitatins Limitatins and Exclusins (What is Nt Cvered) Excluded Services: Age 19 and lder Cvered Expenses d nt include expenses incurred fr: prcedures

More information

PHARYNGO-OESOPHAGECTOMY

PHARYNGO-OESOPHAGECTOMY PHARYNGO-OESOPHAGECTOMY This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin Revisin 1.9 July 26, 2017 P02-03 CALA Prgram Descriptin Prficiency Testing Plicy fr Accreditatin TABLE OF CONTENTS TABLE OF CONTENTS...

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-5 (NQF 2372): Breast Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

Fee Schedule - Home Health Care- 2015

Fee Schedule - Home Health Care- 2015 Fee Schedule - Hme Health Care- 2015 01/01/2015 1600 E Century Ave Ste 1 PO Bx 5585 Bismarck ND 58506-5585 www.wrkfrcesafety.cm Cpyright Ntice The five character cdes included in the Nrth Dakta Fee Schedule

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC)

Measure Specific Guidelines for Comprehensive Diabetes Care (CDC) Measure Specific Guidelines fr Cmprehensive Diabetes Care (CDC) Descriptin: Members age 18-75 years f age with diabetes (Type 1 and Type 2)* that had all f the fllwing: *Members in hspice are excluded

More information

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT

1.11 INSULIN INFUSION PUMP MANAGEMENT INPATIENT WOMEN AND NEWBORN HEALTH SERVICE CLINICAL GUIDELINES SECTION A: GUIDELINES RELEVANT TO OBSTETRICS AND GYNAECOLOGY 1 STANDARD PROTOCOLS 1.11 INSULIN INFUSION PUMP MANAGEMENT - INPATIENT Authrised by: OGCCU

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment

More information

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair:

Postoperative Anterior Cruciate Ligament Reconstruction Care WITH meniscus repair: Pstperative Anterir Cruciate Ligament Recnstructin Care WITH meniscus repair: Imprtant Phne Numbers: - Please see the cntact infrmatin abve fr imprtant phne numbers t call. - If yu have cncerns after hurs,

More information

Methadone Maintenance Treatment for Opioid Dependence

Methadone Maintenance Treatment for Opioid Dependence POLICY STATEMENT Methadne Maintenance Treatment fr Opiid Dependence APPROVED BY COUNCIL: May 2010 PUBLICATION DATE: Dialgue, Issue 2, 2010 Disclaimer: As f May 19, 2018 physicians n lnger require an exemptin

More information

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS

Dear Student, IMMUNIZATION RECORD INSTRUCTIONS Dear Student, Welcme t the University f Chicag! The State f Illinis and University regulatins require students t prvide prf f required immunizatins prir t registratin fr classes. In rder t cmplete this

More information

Ontario 2018 provincial election issues backgrounder

Ontario 2018 provincial election issues backgrounder Ontari 2018 prvincial electin issues backgrunder Dietitians f Canada Pririties May 2018 Access t dietitians in Ontari s health system Diet is the #1 risk factr fr chrnic diseases that cst Ontari $90 billin

More information

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage

Rituxan (rituximab) Effective Date: 10/01/2015. Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Rituxan (rituximab) Line(s) f Business: HMO; PPO; QUEST Integratin Akamai Advantage Effective Date: 10/01/2015 POLICY A. INDICATIONS The indicatins belw including FDA-apprved indicatins and cmpendial uses

More information

Michigan Primary Care Transformation Project Performance Incentive Technical Manual

Michigan Primary Care Transformation Project Performance Incentive Technical Manual Michigan Primary Care Transfrmatin Prject 2016 Perfrmance Incentive Technical Manual Fr Physician Organizatins, Physician Hspital Organizatins, Independent Practice Assciatins and Primary Care Practices

More information

CRANIOFACIAL RESECTION

CRANIOFACIAL RESECTION CRANIOFACIAL RESECTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins

More information

Meaningful Use Roadmap Stage Edition Eligible Hospitals

Meaningful Use Roadmap Stage Edition Eligible Hospitals Meaningful Use Radmap Stage 1-2011 Editin Eligible Hspitals CPSI is dedicated t making yur transitin t Meaningful Use as seamless as pssible. Therefre, we have cme up with a radmap t assist yu in implementing

More information

OTHER AND UNSPECIFIED DISORDERS

OTHER AND UNSPECIFIED DISORDERS OPTUM COVERAGE DETERMINATION GUIDELINE OTHER AND UNSPECIFIED DISORDERS Guideline Number: BH727OUD_102017 Effective Date: Octber, 2017 Table f Cntents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Understanding Blood Counts

Understanding Blood Counts Understanding Bld Cunts PMH This pamphlet is fr patients at Princess Margaret Hspital. It will help yu t read and understand the bld cunt infrmatin yu get frm the bld lab. Patient Educatin Imprving Health

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface HTN-2 (NQF 0018): Cntrlling High Bld Pressure Measure Steward: NCQA CMS Web Interface V2.0 Page 1 f 18 11/13/2017 Cntents INTRODUCTION... 3 CMS WEB INTERFACE SAMPLING INFORMATION... 4

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface PREV-6 (NQF 0034): Clrectal Cancer Screening Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION... 4 BENEFICIARY

More information

CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP

CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP I. Intrductin CALVIN JOHNSON JR. FOUNDATION 2015 PANCREATIC CANCER RESEARCH SCHOLARSHIP The Calvin Jhnsn Jr. Fundatin, Inc. (CJJRF) is a nn-prfit 501(c)(3) rganizatin funded in 2008 by Calvin MEGATRON

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF 0055): Diabetes: Eye Exam Measure Steward: NCQA Web Interface

More information

Initial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty.

Initial Postoperative Knee Care Patella or Quadriceps Tendon Repairs: - Videos are available on Dr. Witty s website: drjeffreywitty. Initial Pstperative Knee Care Patella r Quadriceps Tendn Repairs: - Vides are available n Dr. Witty s website: drjeffreywitty.cm Imprtant Phne Numbers: - Please see the cntact infrmatin abve fr imprtant

More information

Medicare Quarterly Update Instructions

Medicare Quarterly Update Instructions Medicare Quarterly Update Instructins Admin Screen RBRVS Prfile Under Admin Prfessinal Calc Engine Management, select RBRVS Prfile. Click Add t add a new RBRVS Prfile Fastlad the apprpriate file frm www.advisry.cm

More information

Creating and Linking Charge Objects

Creating and Linking Charge Objects Overview Charge bject screens are used t maintain cst accunting cdes that agencies use t break ut emplyee time based n wrk perfrmed and leave time while assigned t a specific prject(s). The charge bject

More information

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745 Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES

More information

SCALES NW HEARING PROTECTION PROGRAM

SCALES NW HEARING PROTECTION PROGRAM PURPOSE Expsure t excessive nise in the wrkplace can cause permanent hearing lss. The Hearing Prtectin Prgram has been established t help ensure that emplyees f Scales NW, Inc. d nt suffer health effects

More information

ACRIN 6666 Screening Breast US Follow-up Assessment Form

ACRIN 6666 Screening Breast US Follow-up Assessment Form Screening Breast US Fllw-up Assessment Frm N. Instructins: The frm is cmpleted at 12, 24 and 36 mnths pst initial n study mammgraphy and ultrasund by the Radilgist r RA. Reprt all interim infrmatin related

More information

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013 A Unified Apprach t Cnflict Mineral Cmpliance fr the Tungsten Industry The Westin, Sydney, 23 September 2013 Backgrund Cmpliance f public US dwnstream tungsten users with the reprting requirements f the

More information

2018 CMS Web Interface

2018 CMS Web Interface CMS Web Interface Diabetes Mellitus (DM) Cmpsite (All r Nthing Scring) DM-2 (NQF 0059): Diabetes: Hemglbin A1c (HbA1c) Pr Cntrl (>9%) DM-7 (NQF Measure Steward: NCQA CMS Web Interface V2.1 Page 1 f 26

More information

I am having a Rotator Cuff Repair

I am having a Rotator Cuff Repair I am having a Rtatr Cuff Repair A rtatr cuff repair is surgery t repair a trn tendn in the shulder. The rtatr cuff is a grup f muscles and tendns that frm a cuff ver the shulder jint. The muscles and tendns

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Record of Revisions to Patient Tracking Spreadsheet Template

Record of Revisions to Patient Tracking Spreadsheet Template Recrd f Revisins t Patient Tracking Spreadsheet Template Belw is a recrd f revisins made by the AIMS Center t the Patient Tracking Spreadsheet Template. The purpse f this dcument is t infrm spreadsheet

More information

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH Tpic Circulatin list In case f query please cntact Executive Summary TOP TIPS Lung Cancer Update Dr Andrew Wight Cnsultant respiratry Physician - WUTH All Wirral GP s JaneFletcher2@nhs.net Dear Clleagues,

More information

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES

FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES Appendix h STUDY NUMBER: COST OF UNSAFE ABORTION FOLLOW-UP IN-DEPTH INTERVIEW GUIDELINES T be administered abut 2-3 weeks after leaving the health facility 1. IDENTIFICATION 101. Patient identificatin

More information

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT

Child s Name: Date of Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT Date f Birth: TAKE THIS SHEET TO EVERY DOCTOR S APPOINTMENT Prtable Medical Summary Name: Date Updated: / / Address: Phne: Mbile: E-mail: DOB: SSN: - - Allergies: Pertinent Persnal Characteristics: What

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

Medical Student Immunization Requirements

Medical Student Immunization Requirements Medical Student Immunizatin Requirements The State f Illinis cde, Reference: (110 ILCS 20) Cllege Student Immunizatin Act, requires students t prvide prf f immunity: Measles (Rubela), Mumps, Rubella (German

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA)

Policy. Medical Policy Manual Approved: Do Not Implement Until 1/1/18. Applied Behavioral Analysis (ABA) Plicy Medical Plicy Manual Apprved: D Nt Implement Until 1/1/18 Applied Behaviral Analysis (ABA) This medical plicy will apply t self-funded grups upn their renewal, beginning 1/1/18. Des nt apply t BlueCare.

More information

Pediatric and adolescent preventive care and HEDIS *

Pediatric and adolescent preventive care and HEDIS * Pediatric and adlescent preventive care and HEDIS * * HEDIS is a registered trademark f the Natinal Cmmittee fr Quality Assurance (NCQA). UniCare Health Plan f West Virginia, Inc. Healthcare Effectiveness

More information

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070)

Coronary Artery Disease (CAD): Beta Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI) (NQF 0070) Crnary Artery Disease (CAD): Beta Blcker Therapy fr CAD Patients with Prir Mycardial Infarctin (MI) (NQF 0070) EMeasure Name Crnary Artery Disease EMeasure Id Pending (CAD): Beta Blcker Therapy fr CAD

More information

2017 CMS Web Interface

2017 CMS Web Interface CMS Web Interface CARE-2 (NQF 0101): Falls: Screening fr Future Fall Risk Measure Steward: NCQA Web Interface V1.0 Page 1 f 18 11/15/2016 Cntents INTRODUCTION... 3 WEB INTERFACE SAMPLING INFORMATION...

More information

2016 CWA Political Action Fund Administrative Procedures Checklist

2016 CWA Political Action Fund Administrative Procedures Checklist 2016 CWA Plitical Actin Fund Administrative Prcedures Checklist 1. Dates f Prgram The 2016 CWA Plitical Actin Fund (federal plitical actin cmmittee- CWA-COPE PCC) Prgram will be cnducted n a calendar year

More information

Corporate Governance Code for Funds: What Will it Mean?

Corporate Governance Code for Funds: What Will it Mean? Crprate Gvernance Cde fr Funds: What Will it Mean? The Irish Funds Industry Assciatin has circulated a draft Vluntary Crprate Gvernance Cde fr the Funds Industry in Ireland. 1. Backgrund On 13 June 2011,

More information

Documentation Requirements for LL Prosthetics

Documentation Requirements for LL Prosthetics Ottbck has relied upn the CMS guidance and recmmendatins set frth in this dcument s reference sectin belw. Medicare s Criteria in a Nutshell Medical necessity fr prsthetic cmpnents r additins t the prsthesis

More information

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care. Dental Benefits Under the TeamstersCare Plan, yu and yur eligible dependents have three basic ptins when yu need dental care. Optin #1: TeamstersCare Dentists. Yu can use ur in-huse Charlestwn, Chelmsfrd,

More information

5.0: Rare Bleeding Disorders

5.0: Rare Bleeding Disorders 5.0: Rare Bleeding Disrders 5.1: General Infrmatin Rare bleeding disrders (RBDs) include deficiencies f factrs I (Fibringen), II, V, VII, X, XI and XIII. These deficiencies can be severe r mild. Severe

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

SPECIALTY OF VASCULAR SURGERY Delineation of Clinical Privileges

SPECIALTY OF VASCULAR SURGERY Delineation of Clinical Privileges SPECIALTY OF VASCULAR SURGERY Delineatin f Clinical Privileges Criteria fr granting privileges: Current certificatin by the American Bard f Surgery, r the American Ostepathic Bard f Surgery, and subspecialty

More information

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth.

Head and neck cancers are often treated with radiotherapy. Radiotherapy can lead to faster rates of tooth decay and poor healing in the mouth. DENTAL EXTRACTION This infrmatin aims t help yu understand the peratin, what is invlved and sme cmmn cmplicatins that may ccur. It may help answer sme f yur questins and help yu think f ther questins that

More information

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10 Pdcast Transcript Title: Cmmn Miscding f LARC Services Impacting Revenue Speaker Name: Ann Finn Duratin: 00:16:10 NCTCFP: Welcme t this pdcast spnsred by the Natinal Clinical Training Center fr Family

More information

ICD-10-CM Coding Basics Chapter Specifics

ICD-10-CM Coding Basics Chapter Specifics ICD-10-CM Cding Basics Chapter Specifics Chapter 15 Pregnancy, Childbirth and the Puerperium Vilma Smith, LVN, CPC, CCS Debra Bales, LVN, CPC Jnay Rischer, CPC 1 Rev. May 2015 ICD-10-CM Cnventins General

More information

Ontario s Referral and Listing Criteria for Adult Lung Transplantation

Ontario s Referral and Listing Criteria for Adult Lung Transplantation Ontari s Referral and Listing Criteria fr Adult Lung Transplantatin Versin 2.0 Trillium Gift f Life Netwrk Adult Lung Transplantatin Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The patient referral

More information

Evaluation of Hunter & New England HealthPathways

Evaluation of Hunter & New England HealthPathways Evaluatin f Hunter & New England HealthPathways 2 General Practice & Ambulatry Care Activity General Practice MBS data: In 2013 there were 3.3 millin patient attendances t 730 GPs in the HML regin, a 5.6%

More information

Appendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS

Appendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS Appendix C SCHEDULE OF BENEFITS FOR THE LOW COST MEDICAL PLAN OF BENEFITS The schedule n the fllwing pages highlights key features f the Lw Cst Medical Plan f Benefits fr Cvered Individuals. These benefits

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable* Hereditary Angiedema (HAE) Agents: Berinert (C1 esterase inhibitr [human]), Cinryze (C1 esterase inhibitr [human]), Haegarda (C1 esterase inhibitr [human]) Kalbitr (ecallantide),

More information